Mark For: RAINIER™ trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 88464565 |
Mark Literal Elements | RAINIER |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2019-11-26 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | S. Myers Dill |
Attorney Docket Number | 540843 |
Law Office Assigned | L10 |
Employee Name | LORENZO, GEORGE M |
2019-06-07 | Application Filed |
2019-10-01 | Published |
2019-10-01 | Published for Opposition |
2019-11-26 | Location: INTENT TO USE SECTION |
2019-11-26 | Status: Live/Pending |
2019-11-26 | Status: Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six |
2019-11-26 | Transaction Date |
Party: | ![]() |
Address | 1040 Davis Street, Suite 202 San Leandro, CALIFORNIA UNITED STATES 94577 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
![]() | IMAGE/JPEG | 2019-06-07 |
![]() | APPLICATION/XML,IMAGE/JPEG | 2019-06-07 |
![]() | XML | 2019-08-29 |
![]() | MULTI | 2019-08-30 |
![]() | XML | 2019-09-11 |
![]() | XML | 2019-09-11 |
![]() | APPLICATION/XML | 2019-10-01 |
![]() | APPLICATION/XML | 2019-11-26 |
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical and biological preparations used in the treatment of cancer; pharmaceutical and biological preparations used in active specific immunotherapy for the treatment of cancer
IC 016. US 002 005 022 023 029 037 038 050. G & S: Publications, namely, printed research papers and articles in the fields of pharmaceuticals, biologicals, and clinical trials
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 16 |
U.S. Codes: | 002,005,022,023,029,037,038,050 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical and biological preparations used in the treatment of cancer; pharmaceutical and biological preparations used in active specific immunotherapy for the treatment of cancer |
Description | Date | Proceeding Number |
---|---|---|
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-11-26 | |
PUBLISHED FOR OPPOSITION | 2019-10-01 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-10-01 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-09-11 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-08-29 | |
ASSIGNED TO EXAMINER | 2019-08-28 | 73359 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-06-21 | |
NEW APPLICATION ENTERED IN TRAM | 2019-06-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.